SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-161385
Filing Date
2021-05-14
Accepted
2021-05-14 09:01:38
Documents
36
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d158922d10q.htm 10-Q 213682
2 EX-31.1 d158922dex311.htm EX-31.1 6749
3 EX-31.2 d158922dex312.htm EX-31.2 6754
4 EX-32.1 d158922dex321.htm EX-32.1 3416
5 EX-32.2 d158922dex322.htm EX-32.2 3285
  Complete submission text file 0001193125-21-161385.txt   1398960

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inti-20210331.xml EX-101.INS 143563
7 XBRL TAXONOMY EXTENSION SCHEMA inti-20210331.xsd EX-101.SCH 17866
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inti-20210331_cal.xml EX-101.CAL 18220
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inti-20210331_def.xml EX-101.DEF 100617
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inti-20210331_lab.xml EX-101.LAB 165648
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inti-20210331_pre.xml EX-101.PRE 132024
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 21922142
SIC: 8731 Services-Commercial Physical & Biological Research